News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,220 Results
Type
Article (41612)
Company Profile (463)
Press Release (659145)
Section
Business (208408)
Career Advice (2009)
Deals (35944)
Drug Delivery (92)
Drug Development (83303)
Employer Resources (170)
FDA (16327)
Job Trends (15046)
News (352107)
Policy (32982)
Tag
Academia (2623)
Alliances (50614)
Alzheimer's disease (1274)
Approvals (16252)
Artificial intelligence (139)
Bankruptcy (361)
Best Places to Work (11737)
Biotechnology (349)
Breast cancer (124)
Cancer (1121)
Cardiovascular disease (102)
Career advice (1677)
Cell therapy (250)
Clinical research (66013)
Collaboration (409)
Compensation (202)
COVID-19 (2590)
C-suite (100)
Data (1145)
Diabetes (156)
Diagnostics (6199)
Earnings (86048)
Employer resources (148)
Events (112948)
Executive appointments (316)
FDA (16877)
Funding (371)
Gene therapy (194)
GLP-1 (613)
Government (4411)
Healthcare (18998)
Infectious disease (2675)
Inflammatory bowel disease (113)
Interviews (311)
IPO (16580)
Job creations (3695)
Job search strategy (1430)
Layoffs (439)
Legal (7928)
Lung cancer (174)
Manufacturing (181)
Medical device (13323)
Medtech (13328)
Mergers & acquisitions (19434)
Metabolic disorders (427)
Neuroscience (1565)
NextGen Class of 2024 (6735)
Non-profit (4534)
Northern California (1501)
Obesity (246)
Opinion (198)
Patents (103)
People (57638)
Phase I (20686)
Phase II (29143)
Phase III (21550)
Pipeline (462)
Postmarket research (2591)
Preclinical (8884)
Radiopharmaceuticals (252)
Rare diseases (235)
Real estate (5998)
Regulatory (21965)
Research institute (2405)
Resumes & cover letters (351)
Southern California (1328)
Startups (3747)
United States (13929)
Vaccines (566)
Weight loss (184)
Date
Today (39)
Last 7 days (684)
Last 30 days (3688)
Last 365 days (36754)
2024 (33762)
2023 (41013)
2022 (52276)
2021 (56771)
2020 (54928)
2019 (47424)
2018 (35704)
2017 (33025)
2016 (32349)
2015 (38397)
2014 (32187)
2013 (27109)
2012 (29220)
2011 (29865)
2010 (27993)
Location
Africa (731)
Arizona (200)
Asia (38520)
Australia (6404)
California (3431)
Canada (1302)
China (257)
Colorado (151)
Connecticut (163)
Europe (84003)
Florida (465)
Georgia (116)
Illinois (354)
Indiana (199)
Kansas (99)
Maryland (590)
Massachusetts (2735)
Michigan (160)
Minnesota (279)
New Jersey (975)
New York (980)
North Carolina (760)
Northern California (1501)
Ohio (141)
Pennsylvania (856)
South America (1105)
Southern California (1328)
Texas (481)
Utah (92)
Washington State (376)
701,220 Results for "viewpoint therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Centerline Biomedical celebrates first on-label surgical case at the University of Virginia Health System with the 6Fr Viewpoint™ Catheter
November 20, 2024
·
2 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Business
Defence and Viewpoint with Dennis Quaid Join Forces to Explore Breakthroughs in Biotechnology
Defence Therapeutics Inc. (“Defence” or the “Company”) a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies is pleased to announce its collaboration with Viewpoint with Dennis Quaid.
July 5, 2023
·
4 min read
Defence’s Innovative Therapeutics Featured on Viewpoint with Dennis Quaid
Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (“Defence” or the “Company”) a Canadian biopharmaceutical company developing novel immune-oncology vaccines
September 5, 2023
·
4 min read
FDA
Centerline Biomedical receives FDA 510(k) clearance for new IOPS® Viewpoint Catheter, further addressing market need to reduce physician exposure to harmful x-ray radiation during image-guided, endovascular procedures
August 6, 2024
·
2 min read
BioMidwest
Viewpoint Molecular Targeting Announces First Neuroendocrine Tumor Patients Dosed with Therapeutic Intent
Viewpoint Molecular Targeting®, Inc., a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents, today announced the first dosing of two neuroendocrine tumor patients with therapeutic intent.
January 23, 2023
·
3 min read
Deals
Visus Therapeutics Expands Ophthalmic Drug Development Portfolio With Acquisition of ViewPoint Therapeutics’ Assets
Visus Therapeutics Inc. today announced it has expanded its pipeline via the acquisition of all patents and other assets of ViewPoint Therapeutics.
September 28, 2022
·
4 min read
Press Releases
Versant Ventures Unveils Pep2Tango Therapeutics Inc.
November 21, 2024
·
4 min read
Press Releases
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
November 13, 2024
·
4 min read
Business
Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
Gain Therapeutics, Inc. announces that Matthias Alder has departed the Company in order to pursue other opportunities.
June 27, 2024
·
5 min read
1 of 70,122
Next
